Aims: In the present study we have investigated the comparative switching propensity of murine peritoneal and splenic B cell subpopulations to IgA in presence of retinoic acid (RA) and TGF-b. Conclusion: Present study demonstrates the differential and synergistic effect of RA and TGF-b on switching of different B cell subpopulations to IgA and establishes the prominence of peritoneal B1b cells in switching to IgA under the influence of these two factors. Our study extends our knowledge about the existing differences among B cell subpopulations with regards to IgA production and indicates towards their differential contribution to gut associated humoral immunity.
Introduction
IgA is the most abundant class of antibodies present in mammalian mucosal tissues. It forms a first-line of defense against invasion by inhaled or ingested pathogens and plays an important role in the maintenance of immune homeostasis. Besides mucosal tissues, IgA is also found at significant concentrations in the serum of many species, where it mediates the elimination of pathogens that have breached the mucosa. [1] Class switch recombination (CSR) to IgA is orchestrated by various cytokines and other factors. [2] [3] [4] Amongst them, TGF-b and retinoic acid (RA) are most prominent. [2, 5] A special role of TGF-b in IgA CSR is most evident from the observation that mice deficient for TGF-b or lacking TGF-b receptor II expression on B cells exhibit reduced levels of IgA. [6, 7] In gut, TGF-b is produced by B cells (autocrine factor) [8, 9] , T cells [10] dendritic cells (DCs) [11] , and stromal cells. [12] Some of the T cells that produce TGFb are claimed to be Foxp3 + CD4 + regulatory T cells. [2] Besides TGF-b, vitamin A metabolite RA is also a highly potent inducer of IgA CSR. [5] RA is produced by gut associated DCs and macrophages. [13] [14] [15] In accordance, the generation of IgA secreting cells (SCs) and their homing to gut is promoted by intestinal DCs and appears to be dependent on RA. [13] Consistently, mice deficient in RA precursor vitamin A showed reduced numbers of IgA producing cells in the small intestine even though the IgA levels in the serum remained unchanged. [13] The interplay between TGF-b and RA is still controversially discussed. It has been demonstrated that TGF-b inhibits RA induced IgA CSR. [13] However, another study using splenic cells showed that a combination of RA and TGF-b with additional factors (LPS, APRIL, and IL5) acts synergistically to induce IgA switching in vitro. [16] In addition to TGF-b and RA, cytokines, like IL2, IL4, IL5, IL6 and IL10, are also thought to induce CSR and promote IgA production either via TGF-b induction within B cells or by enhancing the post-switch maturation. [4] Furthermore, cytokines of the tumor necrosis factor (TNF) ligand family called B cell activating factor (BAFF/BLyS) and a proliferation inducing ligand (APRIL) produced by gut DCs are also considered to be involved in IgA switching. [17, 18] In mice, at least three mature B cell subpopulations -follicular (FO), marginal zone (MZ) and B1 B cells constitute the humoral immune response, where B1 cells can be subdivided further into B1a and B1b cells. [19, 20] FO B cells also known as B2 cells are present in the B cell follicles of secondary lymphoid organs and respond to antigens T cell dependently. On the other hand, MZ B cells residing in the splenic marginal zone and B1 cells predominantly located in the peritoneal cavity (PEC) or pleural cavity, are believed to respond to antigens without T cell help and play an important role in the early stages of pathogenic invasion. [21] Such B cells respond differentially to various stimuli and need multiple triggers to induce IgA class switching. [16, [22] [23] [24] Thus, under minimal stimulatory conditions (BLys+LPS+TGF-b) they switch to IgA preferentially in comparison to B2 cells from PEC or spleen. [24] The contribution of B1 cell subsets to IgA production in vivo is not known. In this regard, we could recently show that most of the IgA producing cells in the PEC of unmanipulated mice belonged to B1b cell population. [25] However, differential switching of B1a and B1b cells to IgA under stimulatory culture conditions has not been comparatively studied. In addition, the combination of TGFb and RA that was supposed to have synergistic effects on naïve splenic B cells to switch to IgA [16] was never tested on various peritoneal and splenic B1 cell subsets.
Thus, in the present work, we stimulated peritoneal B1a, B1b and B2 cells with LPS, BLys and TGF-b in vitro. Switching to IgA was severely enhanced in peritoneal B1b cells in comparison to their B1a and B2 counterparts. Switching to IgA was further enhanced when TGF-b was combined with RA and IL5. In vitro switched B1 cells also showed the presence of frequent nucleotide exchanges in their functionally rearranged VH gene segments. This indicates that besides IgA CSR, somatic hypermutation had also taken place. These findings could be extended in part also to splenic B1a and MZ B cells. Altogether, these findings demonstrate differential switching of B cell subpopulations to IgA in response to various stimuli in vitro. This suggests alternative mechanisms regulating the IgA CSR of different B cell subsets in vivo.
Materials and Methods

Ethic Statement
All experiments were performed in accordance with the German Law on Care and Use of Laboratory Animals and were approved by the local authority (LAVES) under permission number 33.9-42502-04-11/0390.
Mice
Normal BALB/c mice, 7-10 weeks old, used for the experiments were purchased from Janvier. Rag1 -/-mice on BALB/c background were obtained from our animal facility (Helmholtz Institute for Infection Research; Braunschweig, Germany).
Cell preparation, FACS analysis and cell sorting
To prepare PEC cells, peritoneum was flushed two times with 8 ml of normal cell culture medium (IMDM), collected washout was centrifuged and the pellet was resuspended in appropriate amount of cell culture medium. Monoclonal antibodies against mouse CD19, CD5, CD43, Mac-1, IgA, IgM, CD23, CD21, CCR9 and a 4 b 7 conjugated with FITC, PE, APC, PE-Cy7, or Biotin were obtained from Pharmingen or eBioscience or were home made. Biotinylated antibodies were revealed by Streptavidin-PerCPCy5.5 (eBioscience). Flow cytometry was done using LSR II (BD) and data were analyzed using FACS DIVA software. Cell sorting was performed using FACSAriaH (Becton Dickinson). Reanalysis showed that cells were .95% pure 
RT-PCR
Cell culture and ELISPOT assay
Purified peritoneal and splenic B cell populations, resuspended in IMDM at a density of approximately 1610 5 cells/ml were stimulated with, LPS (25 mg/ml; Escherichia coli, Sigma), Recombinant Mouse BLys (100 ng/ml; R&D SYSTEMS), Recombinant Human TGF-b1 (2 ng/ml; R&D SYSTEMS), IL4 (1:400; home made), IL5 (1:400; home made), and all trans-Retinoic Acid (100 nM; Sigma). ELISPOT: single-cell suspensions at serial dilutions of 1:5 were plated on plates coated with anti-mouse IgA (Pharmingen) or anti-mouse IgM (Pharmingen). Cells were incubated overnight at 37uC with 5% CO 2 and 95% humidity. After washing with PBS+0.01% Tween 20, biotinylated anti-mouse IgA (eBioscience) or antimouse IgM (SeroTec) was added. Bound antibodies were developed with Streptavidin-horseradish peroxidase using AEC (3-amino-9-ethyl-carbazole; Sigma) in DMF (N,N-Dimethylformamide; Sigma) diluted in 0.1 M acetate solution added with H 2 O 2 as substrate. Spot development was stopped by washing plates with water and spots marking antibody secreting cells (ASCs) were counted after drying.
ELISA
Ig concentrations in serum or intestinal lavage were measured by ELISA. In brief, 96 well plates (MaxiSorb TM Immunoplates, Nunc) were coated over night with anti-mouse IgA (Pharmingen) or anti-mouse IgM (Pharmingen) or goatanti-mouse IgG (Sigma) antibodies at 4 C and blocked for 1 h with 3% BSA in 0.05% Tween 20. Appropriately diluted culture supernatant/sera/intestinal lavage from each mouse was added to the wells and incubated for 2 h at RT. Bound IgA/ IgM/IgG was detected with biotinylated rat anti-mouse IgA (eBioscience) or rat-anti-mouse IgM (SeroTec) or PO conjugated goat-anti-mouse IgG (Jackson ImmunoResearch) antibodies. Biotinylated antibodies were revealed by using horseradish peroxidase (HRP) conjugated streptavidin (BD). Bound HRP activity was visualized using o-Phenylendiamin (OPD) as substrate and the results were read using an ELISA-reader (BioRad 3550-UV microplate reader).
In vivo adoptive transfer
Sort purified PEC B1a and B1b cells cultured under different stimulatory conditions for 3 days were collected, washed, resuspended in PBS and injected i.p into Rag1 -/-hosts.
Statistics
Paired two-tailed Student's t-test was applied to determine the statistical significance (p value). p#0.05 was considered significant. *p,0.05; **p,0.01; ***p,0.001.
Results
Peritoneal cavity B1b cells switch preferentially to IgA in presence of TGF-b TGF-b has been known to promote switching of B cells to IgA in general. [2, 26, 27] Under the influence of this cytokine, combined with LPS and Blys, differential propensity of switching to IgA was observed among PEC and splenic B cell subtypes. [24] Interestingly, under such conditions, PEC B1 and splenic MZ B cells switched in vitro to IgA more prominently in comparison to PEC or splenic B2 cells. However, in this study, B1 cells were not differentiated into B1a and B1b cells and thus their differential capability to switch to IgA was not established. [24] Our previous in vivo finding had suggested differences between PEC B1a and B1b cells in that respect. [25] This prompted us to test their preferences to switch to IgA under in vitro stimulatory conditions. For this purpose, PEC B cells were FACS purified into -B1a, B1b and B2 cells ( Figure S1 ). B cells expressing surface IgA were sorted out to exclude expansion of such cells in vitro. 
Pronounced switching of B1 cells to IgA when TGF-b is combined with RA
RA has been shown to promote the switching of naïve splenic B cells to IgA. [16] The differential effect of this vitamin A metabolite on various PEC and splenic B cell subpopulations has not been studied so far. Therefore, to examine the influence of RA on PEC and splenic B cell subpopulations, sorted peritoneal and splenic B cells were subjected in vitro to different combinations of stimulatory factors including RA. After 4 days of activation, the number of IgA and IgM SCs were measured by ELISPOT assay. Consistent with earlier findings, considerably high numbers of IgA SCs were observed in the PEC B cell cultures supplemented with RA plus TGF-b, although these reagents alone in combination with other factors induced comparatively low numbers of IgA SCs (Figure 2A ). Interestingly, under these circumstances, again PEC B1a and B2 cells had significantly less number of IgA ASCs than B1b cells. No differences in the numbers of IgM ASCs were observed under the condition (LPS+Blys+TGF-b+IL5+RA) in which, very high number of IgA ASCs was observed (Figure 2A ). This finding was further confirmed by ELISA that was done to determine the amount of IgA in the culture supernatants of the cultured PEC B cells ( Figure 2B ). Consistently, PEC B1 cells also showed the expression of Iga germ line transcripts after combined treatment with TGF-b and RA ( Figure S2 ). When tested for the reactivity against gut bacteria, secretory IgA present in the culture supernatant of PEC B cells showed their binding towards these commensals ( Figure S3 ). This is consistent with our previous finding that showed the binding of B1 cell derived Igs to gut bacteria [28] . Furthermore, analysis of secretory IgG in the culture supernatants showed that the amount of IgG decreased to a minimum under conditions that favored the switching to IgA ( Figure 2B ). Interestingly, under other conditions, the amount of secretory IgG was found to be higher in B1b cell culture Among splenic B cell subpopulations (FACS sorted according to the plan showed in Figure S1 ), mainly B1a and MZ B cells underwent pronounced switching to IgA compared to splenic B2 cells when treated with TGF-b plus RA ( Figure 3A, B) . Addition of IL5 to the combination of RA and TGF-b did not increase the number of IgA ASCs ( Figure 3A) . Presence of secretory IgA in the supernatants of cultured B cells as determined by ELISA was consistent with the ELISPOT results ( Figure 3A, B) . IgG production seemed to take place without the addition of TGF-b or retinoic acid. However, TGF-b or RA appeared respectively to suppress or enhance the production of IgG in case of splenic B1a cells, (Figure 3B ).
Cell counts of cultured cells indicated strongly reduced proliferation of all PEC and splenic B cell types in presence of TGF-b and RA wherever IL5 was not added (Table 1) . This is consistent with the recent finding showing strong inhibition of B cell proliferation in the cultures added with RA and TGF-b [29] .
In addition, these B cell types showed an uneven increase in their number under various culture conditions (Table 1 ). This might account for the slight differences between ELISPOT and ELISA data, later being only qualitative under these circumstances.
In vitro differentiated B1 cells also exhibit somatic hypermutations
The enzyme AID responsible for CSR also mediates somatic hypermutation (SHM). Consistent with that, we had detected the expression of AID among B cell populations cultured under stimulatory conditions (data not shown). Thus, quite expectedly, analysis of IgA VH sequences from PEC B1 cell and splenic B1a cell cultures supplemented with TGF-b or a combination of TGFb and RA exhibited the presence of frequent mutations ( Figure 4A ). Mutation frequencies observed under IgA CSR inducing culture conditions were higher compared to unstimulated B cells ( Figure 4A ). Interestingly, frequent nucleotide exchanges were also detected amongst IgM VH sequences derived from in vitro stimulated B1 cells, ( Figure 4A ). Almost all of the VH sequences were found to be functional and devoid of stop codons or frame shift mutations in the coding VH region ( Table 2) . Analysis of replacement (R) vs. silent (S) mutation revealed a high R/S ratio in the VH regions ( Figure 4B ).
Retinoic acid enhances the expression of gut homing molecules by B1 cells
Besides the induction of IgA switching, retinoic acid is known to induce the expression of gut homing surface receptors (a4b7 and CCR9) on target B and T cells. [5, 14] CCR9 is a chemokine receptor for CCL25 which is secreted by gut epithelial cells and a4b7 is an integrin that binds to the mucosal adressin MadCAM. [30, 31] Expression of these two molecules was expected to be induced after in vitro treatment of peritoneal and splenic B cell subpopulations with TGF-b and RA as IgA producing plasma blasts are supposed to home to intestine. Consistent with earlier findings, treatment with RA led to high surface expression of a4b7 and/or CCR9 on some of the treated PEC and splenic B cells ( Figure 5A, B) . Without RA, no influence of TGF-b or IL5 on the expression of such molecules was observed ( Figure 5A, B) . However, addition of IL5 to RA with or without TGF-b appeared to enhance the expression of CCR9 on the treated B cell surface ( Figure 5A, B) . Notably, considerable percentages of B cells expressed either a4b7 or CCR9 on their surface though double expressers were found to be present as well ( Figure 5A, B) . Under these conditions, PEC B1a and B1b cells showed higher percentages of B cells expressing these two molecules in comparison to PEC B2 cells ( Figure 5A ). Among splenic B cells, B1a and MZ cells were also higher for such markers in comparison to B2 cells ( Figure 5B ). Thus, expression of these gut homing molecules seemed to be consistent with the switching tendency of B cell subpopulations to IgA as observed above as well as when checked for the expression of surface IgA on PEC and splenic B cell subpopulations (cultured under various stimulatory conditions) by flow cytometry (Figure 2, Figure 3 and Figure 5C , D). The expression of gut homing molecules -a4b7 and CCR9 after TGF-b and RA treatment should render these cells capable of migrating to the gut. Therefore, the migratory capacity of such B cells was tested by adoptive transfer experiment. PEC B1a and B1b cells treated in vitro with RA and TGF-b for three days were adoptively transferred into lymphopenic Rag1 -/-recipients. Day three was chosen because high expression of Iga germ line transcripts could be detected after this period of treatment ( Figure  S2 ). The recipients were analyzed 2 weeks after transfer for the presence of IgA and IgM ASCs in the spleen, and the peritoneal cavity as well as for the secretory IgA and IgM in the serum and intestinal lavage. Interestingly, presence of IgA SCs could be detected in the recipients of PEC B1 cells that were triggered with TGF-b or RA ( Figure 6A and Figure S4A ). However, only the splenocytes of recipients of B1b cells treated with TGF-b+RA+IL5 contained considerably high numbers of IgA SCs ( Figure 6A and Figure S4A ). Higher amounts of secretory IgA could be detected in the serum and gut lavage of the recipients of B1a or B1b cells treated with TGF-b+RA+IL5 in comparison to any other recipient groups ( Figure 6B and Figure S4B ). Again the recipients of B1b cells were higher in comparison to B1a cell recipients. Flow cytometric analysis of PEC cells from transfer recipients showed the presence and survival of transferred cells ( Figure S4C) .
Together, these findings demonstrate a synergistic and differential effect of RA and TGF-b on PEC and splenic B cell subpopulations for IgA switching. Surprisingly, B1b cells preferentially switch to IgA independent of T cell help.
Discussion
Peritoneal cavity B cell subpopulations differ from each other with regard to origin, phenotype and function. PEC B1 cells differentiate faster into plasma cells after stimulation with mitogen than B2 cells from the same compartment. [25, 32] In vivo, the two subtypes of B1 cells -B1a and B1b B cells have been shown to react differently to pathogenic infections. [20, 33] In murine infection models, B1a cells have been shown to respond abruptly after infection whereas B1b cells give rise to long lasting memory immunity against certain pathogens. [20, 33] Moreover, these two B1 cell subtypes also have been shown to differ in their ability to produce IgA. [25, 34] Along these lines, recent in vitro studies have demonstrated that compared to peritoneal and splenic B2 cells, PEC B1 cells switch more preferentially to IgA in response to a combination of TGF-b, LPS and BLys. [24] However, in this study no attempt was made to distinguish between two B1 cell subtypes. Our previous finding that among PEC B cells, almost exclusively, B1b cells had switched to IgA in vivo [25] TGF-b together with RA has recently been shown to induce IgA switching synergistically. [16] In the present study, we used this knowledge to determine the propensity of different peritoneal and splenic B cell subtypes to switch to IgA in response to RA with or without TGF-b. The combined effect of these two factors together with LPS, IL5 and BLys was much stronger than any other combination of stimulants. Again, the frequency of switching to IgA among PEC B cells was significantly higher in B1b cells compared to other PEC B cell types. Interestingly, among splenic B cells, B1a and MZ B cells showed significantly higher IgA CSR than B2 cells. Low switching frequency observed among PEC and splenic B2 cells can be explained by the fact that they require additional stimuli for proliferation and differentiation. For example, B2 cells expressing higher surface IgD show stronger proliferative response in presence of anti-IgD-Dex which is further enhanced by addition of IL4. [23] The considerable high propensity of splenic B1a cell to switch to IgA is consistent with studies where CD5 expressing splenic B1 cells have been claimed to contribute to IgA production. [35] Besides induction of CSR, the vitamin A metabolite RA is also known to induce or upregulate the expression of gut homing molecules -integrin a4b7 and the chemokine receptor CCR9. [5] Quite consistent with that, in our in vitro experimental set up, we observed an upregulated expression of these two gut homing molecules after treatment with RA. Interestingly, the expression of a4b7or CCR9 was higher under conditions that led to enhanced induction of IgA CSR. PEC and splenic B cell subsets prone to enhanced IgA CSR showed higher expression of these homing molecules on their surface. In agreement with the upregulation of gut homing molecules, when PEC B1 cells, treated with a Isotype switching in B cells is mediated by the enzyme AID. [36] This enzyme is also responsible for nucleotide exchanges leading to somatic hypermutation in the V regions of B cell receptors (BCRs) [36] . Quite expectedly, AID had been found to be expressed in cultured B cells under stimulatory condition. This raised the query whether B cells undergoing IgA CSR also accumulate SHM under our experimental conditions. Interestingly, a considerable fraction of IgA VH sequences derived from RA+TGF-b treated PEC and splenic B1 cells showed nucleotide exchanges. Apparently, like CSR, SHM might also have been induced in vitro. Surprisingly, besides IgA VH sequences, IgM VH sequences derived from the same B cell populations also showed higher frequencies of mutations than unstimulated controls.
SHM in vivo results in affinity maturation of a particular BCR. [37] This is however accompanied by the generation of many nonfunctional BCRs due to the introduction of nonsense nucleotides by SHM. In accordance, one would expect to find many non-functional VH sequences under in vitro conditions. This was apparently not the case. The simplest explanation would be that B cells that had already undergone SHM, and started IgA CSR, are selectively expanded under our culture conditions. Such cells might be qualitatively or quantitatively distinct from B cells that had not yet undergone such processes. Signaling molecules or transcription factors might be up-or down-regulated in this state and the cells might preferentially respond to the stimuli in vitro. Alternatively, IgA CSR and SHM were induced in vitro. The low frequency of non-functional VH could be explained by an intrinsic selection mechanism to generate functional BCRs. It is known that nonfunctional mRNAs are recognized and such cells might be eliminated. [38] Also B cells producing nonfunctional nonsecretable VH or VL chains might be deleted by intrinsic mechanisms. This would imply a strong first round of selection for functional BCRs independent of antigen recognition.
B1 cells are generally believed to react independent of CD4 T cell help. [39, 40] Our findings are quite consistent with this notion. The fact that cytokines together with RA efficiently induced CSR and SHM in such cells without interaction with T cells or the involvement of CD40/CD40L suggests that B1 cells indeed can undergo differentiation without T cell help. This is in contrast with the earlier report where signaling through BCR, CD40 and CD38 were shown to be necessary for the in vitro induction of mutations presumably in B2 cells. [41] The factors required for such differentiation are probably provided in vivo by stroma or myeloid cells like intestinal DCs or macrophages. B cells themselves could be the source of some of such factors under in vivo conditions but also T cells interacting with such B1 cells in a non-cognate fashion might be involved.
In conclusion, our work shows that under stimulatory conditions in vitro, PEC B1b cells switch to IgA with a higher propensity in comparison to PEC B1a or B2 cells. The differences among splenic B cell subpopulations with regard to induced switching to IgA are also quite evident. The results of this study show differential stimulatory requirements for different B cell subsets and suggest the presence of distinct mechanisms regulating the induction of IgA CSR among them. + B cells in the peritoneum of recipient mice were determined by flow cytometry. PEC cells from individual recipient mouse were analyzed by flow cytometry. Per group, 3-4 mice were used as recipients. Cells pooled from the recipients belonging to the same group were used for ELISPOT assay and it was done in triplicates. Bars represent mean 6 SD. (TIF)
